Assessment of Arterial Involvement in Pancreatic Cancer: Utility of Reconstructed CT Images Perpendicular to Artery
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Patients
2.2. CT Protocols and Contrast Material Injection
2.3. Creation of Perpendicular Reconstructed CT Images and Selection of Pathological Specimen
2.4. CT Image Analysis
2.5. Reference Standard
2.6. Statistical Analysis
3. Results
3.1. Patients’ Demographics and Tumor Characteristics
3.2. Pathological and Radiological Measurements of Solid Soft-Tissue Contact
3.3. Diagnostic Performance in the Current and Proposed Methods
3.4. Interobserver Variability
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- NCCN. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma, Version 2; National Comprehensive Cancer Network: Fort Washington, PA, USA, 2024. [Google Scholar]
- Joo, I.; Lee, J.M.; Lee, E.S.; Son, J.-Y.; Lee, D.H.; Ahn, S.J.; Chang, W.; Lee, S.M.; Kang, H.-J.; Yang, H.K. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement. Radiology 2019, 293, 343–349. [Google Scholar] [CrossRef]
- Brugel, M.; Link, T.M.; Rummeny, E.J.; Lange, P.; Theisen, J.; Dobritz, M. Assessment of vascular invasion in pancreatic head cancer with multislice spiral CT: Value of multiplanar reconstructions. Eur. Radiol. 2004, 14, 1188–1195. [Google Scholar] [CrossRef]
- Ahmed, S.A.; Mourad, A.F.; Hassan, R.A.; Ibrahim, M.A.E.; Soliman, A.; Aboeleuon, E.; Elbadee, O.M.A.; Hetta, H.F.; Jabir, M.A. Preoperative CT staging of borderline pancreatic cancer patients after neoadjuvant treatment: Accuracy in the prediction of vascular invasion and resectability. Abdom. Radiol. 2021, 46, 280–289. [Google Scholar] [CrossRef]
- Loizou, L.; Albiin, N.; Ansorge, C.; Andersson, M.; Segersvärd, R.; Leidner, B.; Sundin, A.; Lundell, L.; Kartalis, N. Computed tomography staging of pancreatic cancer: A validation study addressing interobserver agreement. Pancreatology 2013, 13, 570–575. [Google Scholar] [CrossRef]
- Noda, Y.; Kawai, N.; Kaga, T.; Ishihara, T.; Hyodo, F.; Kato, H.; Kambadakone, A.R.; Matsuo, M. Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: Comparison with pancreatic protocol CT. Abdom. Radiol. 2022, 47, 2835–2844. [Google Scholar] [CrossRef]
- Noda, Y.; Pisuchpen, N.; Mercaldo, N.D.; Sekigami, Y.; Michelakos, T.; Parakh, A.; Wo, J.Y.; Qadan, M.; Ferrone, C.; Lillemoe, K.D.; et al. Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy. Eur. Radiol. 2022, 32, 2470–2480. [Google Scholar] [CrossRef]
- Senn, S. Review of Fleiss, statistical methods for rates and proportions. Res. Synth. Methods 2011, 2, 221–222. [Google Scholar] [CrossRef]
- Morgan, D.E.; Waggoner, C.N.; Canon, C.L.; Lockhart, M.E.; Fineberg, N.S.; Posey, J.A., 3rd; Vickers, S.M. Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: A challenge for MDCT. AJR Am. J. Roentgenol. 2010, 194, 615–622. [Google Scholar] [CrossRef]
- Kim, Y.-E.; Park, M.-S.; Hong, H.-S.; Kang, C.M.; Choi, J.-Y.; Lim, J.S.; Lee, W.J.; Kim, M.-J.; Kim, K.W. Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer. Radiology 2009, 250, 758–765. [Google Scholar] [CrossRef]
- Noda, Y.; Mizuno, N.; Kawai, N.; Ando, T.; Kawaguchi, M.; Nagata, S.; Fujimoto, K.; Nakamura, F.; Kaga, T.; Ishihara, T.; et al. Determination of arterial invasion in pancreatic ductal adenocarcinoma: What is the best diagnostic criterion on CT? Eur. Radiol. 2023, 33, 3617–3626. [Google Scholar] [CrossRef]
- Puleo, A.; Malla, M.; Boone, B.A. Defining the Optimal Duration of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Time for a Personalized Approach? Pancreas 2022, 51, 1083–1091. [Google Scholar] [CrossRef]
- Healy, G.M.; Redmond, C.E.; Murphy, S.; Fleming, H.; Haughey, A.; Kavanagh, R.; Swan, N.; Conlon, K.C.; Malone, D.E.; Ryan, E.R. Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: Does the time interval between CT and surgery affect survival? Abdom. Radiol. 2018, 43, 620–628. [Google Scholar] [CrossRef]
- Sanjeevi, S.; Ivanics, T.; Lundell, L.; Kartalis, N.; Andren-Sandberg, A.; Blomberg, J.; Del Chiaro, M.; Ansorge, C. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br. J. Surg. 2016, 103, 267–275. [Google Scholar] [CrossRef]
- Soloff, E.V.; Al-Hawary, M.M.; Desser, T.S.; Fishman, E.K.; Minter, R.M.; Zins, M. Imaging Assessment of Pancreatic Cancer Resectability after Neoadjuvant Therapy: AJR Expert Panel Narrative Review. AJR Am. J. Roentgenol. 2022, 218, 570–581. [Google Scholar] [CrossRef]
Parameter | Revolution CT | Discovery CT750 HD | ||
---|---|---|---|---|
Scan mode | Single-energy | Dual-energy | Single-energy | Single-energy |
Tube voltage (kVp) | 120 | 80/140 | 120 | 80 |
mA modulation | Auto mA and Smart mA | GSI Assist | Auto mA and Smart mA | Auto mA and Smart mA |
Noise index (HU) | 10.0 HU (at 5 mm slice thickness and ASiR-V 40%) | 8.5 HU (at 5 mm slice thickness and ASiR-V 40% at 70 keV) | 10.0 HU (at 5 mm slice thickness and FBP) | 10.0 HU (at 5 mm slice thickness and FBP) |
Detector configuration | 128 detectors with 0.625 mm section thickness | 128 detectors with 0.625 mm section thickness | 64 detectors with 0.625 mm section thickness | 64 detectors with 0.625 mm section thickness |
Slice thickness/interval (mm) | 1.25/0.625 | 1.25/0.625 | 1.25/0.625 | 1.25/0.625 |
Helical pitch | 0.992:1 | 0.992:1 | 0.516:1 | 0.516:1 |
Rotation time (s) | 0.5 | 0.5 | 0.4 | 0.4 |
Reconstruction | ASiR-V 40% | TFDL-M | ASiR 30% | ASiR 30% |
Characteristics | Study Sample (n = 36) |
---|---|
Patients’ demographics | |
Age (years) * | 73 ± 8 (59–84) |
Men/Women | 21:15 |
Body weight (kg) * | 55 ± 10 (35–74) |
Height (cm) * | 158 ± 8 (138–176) |
Body mass index (kg/m2) * | 22 ± 3 (16–32) |
CEA (ng/mL) † | 3 (2–5) |
CA 19–9 (U/mL) † | 66 (27–311) |
Neoadjuvant chemotherapy (+/−) | 17/19 |
Tumor characteristics | |
Histological type of pancreatic cancer | |
Pancreatic ductal adenocarcinoma | 34 |
Adenosquamous carcinoma | 1 |
Anaplastic carcinoma | 1 |
Tumor size (mm) † | 23 (19–35) |
Tumor location (pancreatic body/tail) | 20/16 |
pT (0/1a/1b/1c/2/3/4) | 0/1/1/9/16/7/1 |
pN (0/1/2) | 15/14/7 |
pM (0/1) | 34/2 |
Pathological arterial invasion (+/−) | 3/33 |
R classification (0/1/2) | 30/6/0 |
Parameter | Pathology | Radiology | |
---|---|---|---|
Tumor Cell Infiltration | Pancreatic Fibrosis |
Perpendicular Reconstructed CT Images | |
All patients (°) | 145 ± 135 | 169 ± 139 | 184 ± 129 |
Pancreatic fibrosis >180° (°) | 258 ± 99 | 295 ± 70 | 287 ± 65 |
Pancreatic fibrosis ≤180° (°) | 44 ± 60 | 57 ± 71 | 92 ± 99 |
Reviewer | Method | Sensitivity | Specificity | PPV | NPV | Accuracy |
---|---|---|---|---|---|---|
All reviewers | Current | 69% (59/85) | 93% (88/95) | 89% (59/66) | 77% (88/114) | 82% (147/180) |
Proposal | 98% (83/85) | 79% (75/95) | 81% (83/103) | 97% (75/77) | 88% (158/180) | |
p value | <0.001 | 0.003 | 0.03 | <0.001 | 0.10 | |
Expert radiologists | ||||||
Reviewer 1 | Current | 53% (9/17) | 90% (17/19) | 82% (9/11) | 68% (17/25) | 72% (26/36) |
Proposal | 100% (17/17) | 79% (15/19) | 81% (17/21) | 100% (15/15) | 89% (32/36) | |
Reviewer 2 | Current | 82% (14/17) | 90% (17/19) | 88% (14/16) | 85% (17/20) | 86% (31/36) |
Proposal | 100% (17/17) | 79% (15/19) | 81% (17/21) | 100% (15/15) | 89% (32/36) | |
Non-expert radiologists | ||||||
Reviewer 3 | Current | 59% (10/17) | 95% (18/19) | 91% (10/11) | 72% (18/25) | 78% (26/36) |
Proposal | 94% (16/17) | 79% (15/19) | 80% (16/20) | 94% (15/16) | 86% (31/36) | |
Reviewer 4 | Current | 88% (15/17) | 95% (18/19) | 94% (15/16) | 90% (18/20) | 92% (33/36) |
Proposal | 100% (17/17) | 79% (15/19) | 81% (17/21) | 100% (15/15) | 89% (32/36) | |
Reviewer 5 | Current | 65% (11/17) | 95% (18/19) | 92% (11/12) | 75% (18/24) | 91% (29/36) |
Proposal | 94% (16/17) | 79% (15/19) | 80% (16/20) | 94% (15/16) | 86% (31/36) |
Method | All Reviewers | Expert | Non-Expert | p Value |
---|---|---|---|---|
Current (95% CI) | 0.67 (0.56, 0.77) | 0.59 (0.28, 0.91) | 0.68 (0.49, 0.87) | 0.32 |
Proposed (95% CI) | 0.87 (0.73, 1.00) | 1.00 (0.55, 1.00) | 0.79 (0.53, 1.00) | 0.21 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Noda, Y.; Kobayashi, K.; Kawaguchi, M.; Ando, T.; Takai, Y.; Suto, T.; Iritani, Y.; Ishihara, T.; Fukada, M.; Murase, K.; et al. Assessment of Arterial Involvement in Pancreatic Cancer: Utility of Reconstructed CT Images Perpendicular to Artery. Cancers 2024, 16, 2271. https://doi.org/10.3390/cancers16122271
Noda Y, Kobayashi K, Kawaguchi M, Ando T, Takai Y, Suto T, Iritani Y, Ishihara T, Fukada M, Murase K, et al. Assessment of Arterial Involvement in Pancreatic Cancer: Utility of Reconstructed CT Images Perpendicular to Artery. Cancers. 2024; 16(12):2271. https://doi.org/10.3390/cancers16122271
Chicago/Turabian StyleNoda, Yoshifumi, Kazuhiro Kobayashi, Masaya Kawaguchi, Tomohiro Ando, Yukiko Takai, Taketo Suto, Yukako Iritani, Takuma Ishihara, Masahiro Fukada, Katsutoshi Murase, and et al. 2024. "Assessment of Arterial Involvement in Pancreatic Cancer: Utility of Reconstructed CT Images Perpendicular to Artery" Cancers 16, no. 12: 2271. https://doi.org/10.3390/cancers16122271
APA StyleNoda, Y., Kobayashi, K., Kawaguchi, M., Ando, T., Takai, Y., Suto, T., Iritani, Y., Ishihara, T., Fukada, M., Murase, K., Kawai, N., Kaga, T., Miyoshi, T., Hyodo, F., Kato, H., Miyazaki, T., Matsuhashi, N., Yoshida, K., & Matsuo, M. (2024). Assessment of Arterial Involvement in Pancreatic Cancer: Utility of Reconstructed CT Images Perpendicular to Artery. Cancers, 16(12), 2271. https://doi.org/10.3390/cancers16122271